High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid-Reference-Cited by-同舟云学术

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid

Published:2016-02-29 Issue:16 Volume:7 Page:21631-21643
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wu Wei¹,Zhu Huayuan¹,Fu Yuan¹,Shen Wenyi¹,Miao Kourong¹,Hong Min¹,Xu Wei¹,Fan Lei¹,Young Ken H.²,Liu Peng¹³,Li Jianyong¹

Affiliation:

1. Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing, China

2. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

3. Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma;Cancers;2024-05-20

2. Deregulation of New Cell Death Mechanisms in Leukemia;Cancers;2024-04-25

3. Effect of aza-BODIPY-photodynamic therapy on the expression of carcinoma-associated genes and cell death mode;Photodiagnosis and Photodynamic Therapy;2023-12

4. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma;Recent Patents on Anti-Cancer Drug Discovery;2023-05

5. Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent;International Journal of Molecular Sciences;2023-04-04